WINDLAS BIOTECH
Back to Cashflow Statement
|
WINDLAS BIOTECH Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-15 Cr | ₹-44 Cr | ₹130 Cr | ₹0.78 Cr | ₹-5.44 Cr |
What is the latest Cash Flow from Financing Activities ratio of WINDLAS BIOTECH ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-15 Cr |
Mar2023 | ₹-44 Cr |
Mar2022 | ₹130 Cr |
Mar2021 | ₹0.78 Cr |
Mar2020 | ₹-5.44 Cr |
How is Cash Flow from Financing Activities of WINDLAS BIOTECH Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-15 Cr | Negative | |
Mar2023 | ₹-44 Cr | Negative | |
Mar2022 | ₹130 Cr | 16,663.92 | |
Mar2021 | ₹0.78 Cr | Positive | |
Mar2020 | ₹-5.44 Cr | - |
Compare Cash Flow from Financing Activities of peers of WINDLAS BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WINDLAS BIOTECH | ₹2,032.1 Cr | 4% | 1.4% | 116% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹415,697.0 Cr | 0.6% | -2.1% | 16.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,449.0 Cr | 4.3% | 6.5% | 63.9% | Stock Analytics | |
CIPLA | ₹117,778.0 Cr | 3.6% | 0.2% | 2.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,871.0 Cr | 3% | -8.4% | 0% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,046.2 Cr | 3.2% | -1% | 27.4% | Stock Analytics |
WINDLAS BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WINDLAS BIOTECH | 4% |
1.4% |
116% |
SENSEX | 0.2% |
-0.1% |
7.2% |
You may also like the below Video Courses